- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Bethesda Today
By the People, for the People
Comparing CNBX Pharmaceuticals and BioRestorative Therapies
Analyzing the institutional and insider ownership of the two OTC-traded biotech companies
Published on Feb. 11, 2026
Got story updates? Submit your updates here. ›
This article compares the institutional and insider ownership of CNBX Pharmaceuticals (OTCMKTS:CNBX) and BioRestorative Therapies (OTCMKTS:BRTX), two OTC-traded biotech companies. The data shows that CNBX Pharmaceuticals has significantly higher institutional and insider ownership compared to BioRestorative Therapies.
Why it matters
Strong institutional and insider ownership is generally seen as a positive indicator, suggesting that major investors and company insiders believe the stock is poised for long-term growth. This data provides insight into the market's perception and confidence in the two biotech companies.
The details
The data shows that 98.2% of CNBX Pharmaceuticals shares are held by institutional investors, compared to 69.4% for BioRestorative Therapies. Additionally, 73.5% of CNBX Pharmaceuticals shares are held by company insiders, while only 30.8% of BioRestorative Therapies shares are held by insiders.
- The data is from February 11, 2026.
The players
CNBX Pharmaceuticals Inc.
A clinical stage company that engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer.
BioRestorative Therapies, Inc.
A company that develops therapeutic products and medical therapies using cell and tissue protocols, with a focus on treating chronic back pain and metabolic disorders.
The takeaway
The significantly higher institutional and insider ownership of CNBX Pharmaceuticals compared to BioRestorative Therapies suggests that major investors and company insiders have greater confidence in CNBX's long-term growth potential. This data provides valuable insight for investors evaluating the two OTC-traded biotech companies.
